Cadrenal Therapeutics
CVKD
CVKD
3 hedge funds and large institutions have $1.34K invested in Cadrenal Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$1K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$324 |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$14 |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $1K | 607 | +607 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $324 | 230 | +230 | New |
|
|
3
Wells Fargo
San Francisco,
California
| $14 | 10 | +10 | New |
|